Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Johnson & Johnson, Q3
Johnson & Johnson Stock Rises on Better-Than-Expected Revenue, Adjusted Profit
Key Takeaways Johnson & Johnson shares advanced Tuesday after the pharmaceutical and medical device company posted better third-quarter sales and adjusted profit than expected.Net income fell sharply due to billions in one-time expenses like legal costs.
Johnson & Johnson's stock set to rise, lifted by Q3 results
Johnson & Johnson's stock was up in premarket trades Tuesday after the drugmaker reported better-than-expected third-quarter sales and raised full-year revenue guidance.
Johnson & Johnson: Q3 Earnings Snapshot
The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $2.22 per share. The world's biggest maker of health care products posted revenue of $22.47 billion in the period,
Jets owner Woody Johnson is optimistic at 2-4
Woody Johnson sounds off on optimism for Jets, Davante Adams trade
Woody Johnson is not giving up the vision that his New York Jets could contend for a championship – this season. A day after the Jets fell to 2-4 with a mistake-filled prime-time loss against the Buffalo Bills,
Jets owner Woody Johnson is optimistic at 2-4: 'We’re going to kick…'
There’s proof in the pudding and words when it comes to Jets owner Woody Johnson. Johnson spoke at the NFL owners’ meetings on Tuesday. That happened shortly after the Jets traded for All-Pro receiver Davante Adams.
Woody Johnson: Jets want to bring a lot of change this week
Jets owner Woody Johnson is eager to see his team win, and win this year. Johnson spoke to reporters at the league meeting shortly after news broke that the Jets will be acquiring wide receiver Davante Adams in a trade with the Raiders,
11m
on MSN
Springfield man awarded $15 million after jury finds Johnson and Johnson liable for cancer diagnosis
A Springfield resident and local real estate entrepreneur, Evan Plotkin has just been awarded $15 million after a jury found ...
1d
on MSN
Johnson & Johnson’s stock falls despite Q3 sales beat and guidance raise
Johnson & Johnson reported better-than-expected third-quarter sales and raised its full-year revenue guidance.
12h
Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say
Johnson & Johnson's Q3 2024 results surpassed analyst expectations, reporting $2.42 EPS and $22.47 billion in sales. Updated ...
FiercePharma
11h
Johnson & Johnson sets 'new standard in inclusive marketing' with diverse Tremfya psoriasis ad
Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...
21h
on MSN
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
Third-quarter results exceeded estimates, but the company also lowered overall earnings expectations for 2024.
14h
Johnson & Johnson’s Growth Potential Highlighted by Strong Q3 Earnings and Promising Pipeline
David Risinger, an analyst from Leerink Partners, maintained the Buy rating on Johnson & Johnson (JNJ – Research Report). The ...
1d
on MSN
Deloitte, Johnson & Johnson execs say people aren’t using their health benefits until they are in crisis
“We should all care about health equity because that is one more person who is going to have a challenge to care for their ...
The Motley Fool
1d
Johnson & Johnson Q3 EPS Dips on Charges
The innovative medicine and medtech segments showed solid sales growth.
Johnson
&
Johnson
reported a strong increase in sales, but earnings fell due to one-time charges. In the wake of last year's ...
1d
Johnson & Johnson: Balancing Growth Potential with Market Challenges and Legal Risks
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
KTSM El Paso on MSN
7h
Beto O’Rourke endorses Renard Johnson for El Paso mayor
Former Congressman Beto O’Rourke has endorsed mayoral candidate Renard Johnson, his team announced in a news release on ...
WTIC Hartford on MSN
6h
$15 million asbestos verdict delivered against Johnson & Johnson by Connecticut jury
A jury in Bridgeport awarded the money to a man who reportedly developed mesothelioma because of asbestos in Johnson & ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Q3
Donald Trump
Medtech
Springfield
Pittsburgh Pirates
Feedback